34
Views
1
CrossRef citations to date
0
Altmetric
Patent Evaluation

Long-acting β2 agonists

Pfizer: US20050171147 & US20050182091

Pages 99-104 | Published online: 22 Dec 2005

Bibliography

  • LOTVALL J: Pharmacological similarities and differences between β2-agonists. Respir. Med. (2001) 95(Suppl.B):S7-S11.
  • JACK D: Safety by design. Drug Saf. (1990) 5(Suppl.1):4-23.
  • CAZZOLA M, MATERA MG, LÖTVALL J: Ultra long-acting β2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin. Investig. Drugs (2005) 14:775-783.
  • BROWN AD, BRYANS JS, BUNNAGE ME et al.: Discovery of novel inhaled long acting β2 agonists for asthma and COPD. Poster presentation at 13th RSC-SCI Medicinal Chemistry Symposium, Cambridge, UK (4-7 September 2005).
  • NORMAN P: Respiratory disease markets and opportunities. Clearview Ltd (May 2005).

Patents

Website

  • http://www.gsk.com/financial/pp_pipeline_standard.htm GSK product pipeline.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.